| The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4 A Csibi, SM Fendt, C Li, G Poulogiannis, AY Choo, DJ Chapski, SM Jeong, ... Cell 153 (4), 840-854, 2013 | 661 | 2013 |
| SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism SM Jeong, C Xiao, LWS Finley, T Lahusen, AL Souza, K Pierce, YH Li, ... Cancer cell 23 (4), 450-463, 2013 | 483 | 2013 |
| H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers M Seiler, A Yoshimi, R Darman, B Chan, G Keaney, M Thomas, ... Nature medicine 24 (4), 497-504, 2018 | 466 | 2018 |
| The initiation factor eIF3‐f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy J Lagirand‐Cantaloube, N Offner, A Csibi, MP Leibovitch, ... The EMBO journal 27 (8), 1266-1276, 2008 | 373 | 2008 |
| AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1 AMJ Sanchez, A Csibi, A Raibon, K Cornille, S Gay, H Bernardi, ... Journal of cellular biochemistry 113 (2), 695-710, 2012 | 366 | 2012 |
| The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation A Csibi, G Lee, SO Yoon, H Tong, D Ilter, I Elia, SM Fendt, TM Roberts, ... Current biology 24 (19), 2274-2280, 2014 | 272 | 2014 |
| Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo J Lagirand-Cantaloube, K Cornille, A Csibi, S Batonnet-Pichon, ... PloS one 4 (3), e4973, 2009 | 254 | 2009 |
| Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism SM Fendt, EL Bell, MA Keibler, SM Davidson, GJ Wirth, B Fiske, ... Cancer research 73 (14), 4429-4438, 2013 | 236 | 2013 |
| Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer G Zadra, CF Ribeiro, P Chetta, Y Ho, S Cacciatore, X Gao, S Syamala, ... Proceedings of the National Academy of Sciences 116 (2), 631-640, 2019 | 231 | 2019 |
| The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse A Csibi, K Cornille, MP Leibovitch, A Poupon, LA Tintignac, AMJ Sanchez, ... PloS one 5 (2), e8994, 2010 | 143 | 2010 |
| The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis AMJ Sanchez, RB Candau, A Csibi, AF Pagano, A Raibon, H Bernardi American Journal of Physiology-Cell Physiology 303 (5), C475-C485, 2012 | 133 | 2012 |
| MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines A Csibi, MP Leibovitch, K Cornille, LA Tintignac, SA Leibovitch Journal of biological chemistry 284 (7), 4413-4421, 2009 | 129 | 2009 |
| Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms A Csibi, D Communi, N Müller, SP Bottari PloS one 5 (4), e10070, 2010 | 87 | 2010 |
| Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells C Li, PS Lee, Y Sun, X Gu, E Zhang, Y Guo, CL Wu, N Auricchio, C Priolo, ... Journal of Experimental Medicine 211 (1), 15-28, 2014 | 81 | 2014 |
| Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells J Li, A Csibi, S Yang, GR Hoffman, C Li, E Zhang, JJ Yu, J Blenis Proceedings of the National Academy of Sciences 112 (1), E21-E29, 2015 | 67 | 2015 |
| eIF3f: a central regulator of the antagonism atrophy/hypertrophy in skeletal muscle AMJ Sanchez, A Csibi, A Raibon, A Docquier, J Lagirand-Cantaloube, ... The international journal of biochemistry & cell biology 45 (10), 2158-2162, 2013 | 49 | 2013 |
| eIF3-f function in skeletal muscles: to stand at the crossroads of atrophy and hypertrophy A Csibi, LA Tintignac, MP Leibovitch, SA Leibovitch Cell Cycle 7 (12), 1698-1701, 2008 | 34 | 2008 |
| Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy S Bonazzi, E d’Hennezel, REJ Beckwith, L Xu, A Fazal, A Magracheva, ... Cell Chemical Biology 30 (3), 235-247. e12, 2023 | 33 | 2023 |
| Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumors A Csibi, J Blenis BMC biology 9, 1-5, 2011 | 23 | 2011 |
| Papel de la adrenomedulina cerebelosa en la hipertensión arterial M Pastorello, E Díaz, A Csibi, MR Garrido, JG Chabot, R Quirion, A Israel Archivos Venezolanos de Farmacología y Terapéutica 26 (2), 98-104, 2007 | 13 | 2007 |
Anthony MJ SanchezUniversity of Perpignan Via Domitia - Department of Sports SciencesAdresse e-mail validée de univ-perp.fr
